| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-07 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.0002 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0004 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
0.001 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |